AI/ML-driven Advances in Untargeted Metabolomics and Exposomics for Biomedical Applications

Overview

Journal Cell Rep Phys Sci

Publisher Cell Press

Date 2022 Aug 8

PMID 35936554

Authors

Lauren M Petrick

Noam Shomron

Affiliations

Soon will be listed here.

Abstract

Metabolomics describes a high-throughput approach for measuring a repertoire of metabolites and small molecules in biological samples. One utility of untargeted metabolomics, unbiased global analysis of the metabolome, is to detect key metabolites as contributors to, or readouts of, human health and disease. In this perspective, we discuss how artificial intelligence (AI) and machine learning (ML) have promoted major advances in untargeted metabolomics workflows and facilitated pivotal findings in the areas of disease screening and diagnosis. We contextualize applications of AI and ML to the emerging field of high-resolution mass spectrometry (HRMS) exposomics, which unbiasedly detects endogenous metabolites and exogenous chemicals in human tissue to characterize exposure linked with disease outcomes. We discuss the state of the science and suggest potential opportunities for using AI and ML to improve data quality, rigor, detection, and chemical identification in untargeted metabolomics and exposomics studies.

Citing Articles

Research on Lipidomic Profiling and Biomarker Identification for Osteonecrosis of the Femoral Head.

Yan Y, Wang J, Wang Y, Wu W, Chen W Biomedicines. 2025; 12(12.

PMID: 39767733 PMC: 11673004. DOI: 10.3390/biomedicines12122827.

Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis.

Vo D, Trinh K Int J Mol Sci. 2024; 25(23).

PMID: 39684900 PMC: 11642057. DOI: 10.3390/ijms252313190.

Techniques, Databases and Software Used for Studying Polar Metabolites and Lipids of Gastrointestinal Parasites.

Wangchuk P, Yeshi K Animals (Basel). 2024; 14(18).

PMID: 39335259 PMC: 11428429. DOI: 10.3390/ani14182671.

Artificial Intelligence in Metabolomics: A Current Review.

Chi J, Shu J, Li M, Mudappathi R, Jin Y, Lewis F Trends Analyt Chem. 2024; 178.

PMID: 39071116 PMC: 11271759. DOI: 10.1016/j.trac.2024.117852.

The Millennia-Long Development of Drugs Associated with the 80-Year-Old Artificial Intelligence Story: The Therapeutic Big Bang?.

Crouzet A, Lopez N, Riss Yaw B, Lepelletier Y, Demange L Molecules. 2024; 29(12).

PMID: 38930784 PMC: 11206022. DOI: 10.3390/molecules29122716.

References

van der Hooft J, Mohimani H, Bauermeister A, Dorrestein P, Duncan K, Medema M . Linking genomics and metabolomics to chart specialized metabolic diversity. Chem Soc Rev. 2020; 49(11):3297-3314. DOI: 10.1039/d0cs00162g. View

OShea K, Misra B . Software tools, databases and resources in metabolomics: updates from 2018 to 2019. Metabolomics. 2020; 16(3):36. DOI: 10.1007/s11306-020-01657-3. View

Chetnik K, Petrick L, Pandey G . MetaClean: a machine learning-based classifier for reduced false positive peak detection in untargeted LC-MS metabolomics data. Metabolomics. 2020; 16(11):117. PMC: 7895495. DOI: 10.1007/s11306-020-01738-3. View

Picard M, Scott-Boyer M, Bodein A, Perin O, Droit A . Integration strategies of multi-omics data for machine learning analysis. Comput Struct Biotechnol J. 2021; 19:3735-3746. PMC: 8258788. DOI: 10.1016/j.csbj.2021.06.030. View

Baygi S, Kumar Y, Barupal D . IDSL.IPA Characterizes the Organic Chemical Space in Untargeted LC/HRMS Data Sets. J Proteome Res. 2022; 21(6):1485-1494. PMC: 9177784. DOI: 10.1021/acs.jproteome.2c00120. View

Deng K, Zhao F, Rong Z, Cao L, Zhang L, Li K . WaveICA 2.0: a novel batch effect removal method for untargeted metabolomics data without using batch information. Metabolomics. 2021; 17(10):87. DOI: 10.1007/s11306-021-01839-7. View

Broadhurst D, Goodacre R, Reinke S, Kuligowski J, Wilson I, Lewis M . Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics. 2018; 14(6):72. PMC: 5960010. DOI: 10.1007/s11306-018-1367-3. View

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S . PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 2018; 47(D1):D1102-D1109. PMC: 6324075. DOI: 10.1093/nar/gky1033. View

Myers O, Sumner S, Li S, Barnes S, Du X . One Step Forward for Reducing False Positive and False Negative Compound Identifications from Mass Spectrometry Metabolomics Data: New Algorithms for Constructing Extracted Ion Chromatograms and Detecting Chromatographic Peaks. Anal Chem. 2017; 89(17):8696-8703. DOI: 10.1021/acs.analchem.7b00947. View

10.

Oh T, Kim S, Caussy C, Fu T, Guo J, Bassirian S . A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis. Cell Metab. 2020; 32(5):901. PMC: 7891106. DOI: 10.1016/j.cmet.2020.10.015. View

11.

Pero-Gascon R, Hemeryck L, Poma G, Falony G, Nawrot T, Raes J . FLEXiGUT: Rationale for exposomics associations with chronic low-grade gut inflammation. Environ Int. 2021; 158:106906. DOI: 10.1016/j.envint.2021.106906. View

12.

Huber F, van der Burg S, van der Hooft J, Ridder L . MS2DeepScore: a novel deep learning similarity measure to compare tandem mass spectra. J Cheminform. 2021; 13(1):84. PMC: 8556919. DOI: 10.1186/s13321-021-00558-4. View

13.

Tokareva A, Chagovets V, Kononikhin A, Starodubtseva N, N Nikolaev E, Frankevich V . Normalization methods for reducing interbatch effect without quality control samples in liquid chromatography-mass spectrometry-based studies. Anal Bioanal Chem. 2021; 413(13):3479-3486. DOI: 10.1007/s00216-021-03294-8. View

14.

Varma V, Oommen A, Varma S, Casanova R, An Y, Andrews R . Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLoS Med. 2018; 15(1):e1002482. PMC: 5784884. DOI: 10.1371/journal.pmed.1002482. View

15.

Tsugawa H, cajka T, Kind T, Ma Y, Higgins B, Ikeda K . MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nat Methods. 2015; 12(6):523-6. PMC: 4449330. DOI: 10.1038/nmeth.3393. View

16.

Dekermanjian J, Labeikovsky W, Ghosh D, Kechris K . MSCAT: A Machine Learning Assisted Catalog of Metabolomics Software Tools. Metabolites. 2021; 11(10). PMC: 8540572. DOI: 10.3390/metabo11100678. View

17.

Schollee J, Schymanski E, Stravs M, Gulde R, Thomaidis N, Hollender J . Similarity of High-Resolution Tandem Mass Spectrometry Spectra of Structurally Related Micropollutants and Transformation Products. J Am Soc Mass Spectrom. 2017; 28(12):2692-2704. DOI: 10.1007/s13361-017-1797-6. View

18.

Duhrkop K, Shen H, Meusel M, Rousu J, Bocker S . Searching molecular structure databases with tandem mass spectra using CSI:FingerID. Proc Natl Acad Sci U S A. 2015; 112(41):12580-5. PMC: 4611636. DOI: 10.1073/pnas.1509788112. View

19.

Huber F, Ridder L, Verhoeven S, Spaaks J, Diblen F, Rogers S . Spec2Vec: Improved mass spectral similarity scoring through learning of structural relationships. PLoS Comput Biol. 2021; 17(2):e1008724. PMC: 7909622. DOI: 10.1371/journal.pcbi.1008724. View

20.

Pirttila K, Balgoma D, Rainer J, Pettersson C, Hedeland M, Brunius C . Comprehensive Peak Characterization (CPC) in Untargeted LC-MS Analysis. Metabolites. 2022; 12(2). PMC: 8878835. DOI: 10.3390/metabo12020137. View